The Impact of COPD and Inhaled Corticosteroids on Major Adverse Cardiovascular Events in Populations with Cardiovascular-Kidney-Metabolic Conditions - Takeaways - MDSpire

The Impact of COPD and Inhaled Corticosteroids on Major Adverse Cardiovascular Events in Populations with Cardiovascular-Kidney-Metabolic Conditions

  • By

  • Anne E. Ioannides

  • Emily L. Graul

  • Constantinos Kallis

  • Upasana Tayal

  • Hana Müllerová

  • Jennifer K. Quint

  • March 4, 2026

  • 0 min

Share

  • 1

    COPD patients have a significantly higher risk of major adverse cardiovascular events (MACE) compared to the general population.

  • 2

    The prevalence of COPD is notably higher in cardiovascular-kidney-metabolic (CKM) populations than in the general population.

  • 3

    Inhaled corticosteroids (ICS) may have mixed effects on cardiovascular outcomes in COPD patients, with potential cardioprotective benefits in certain sub-populations.

  • 4

    The study aims to clarify whether COPD is an independent cardiovascular risk factor in CKM populations already at elevated risk for MACE.

  • 5

    Five discrete cohorts were created to investigate the relationship between COPD and MACE among individuals with CKD, T2DM, obesity, and other risk factors.

Original Source(s)

Related Content